Bioequivalence and Food Effect Assessment for Vildagliptin/Metformin Fixed-dose Combination Tablets Relative to Free Combination of Vildagliptin and Metformin in Japanese Healthy Subjects
Nozaki, Sachiko, Chitnis, Shripad, Kulmatycki, Kenneth, Salunke, Atish Azad, He, Yan-Ling, Zhou, Wei and Suzuki, Hikoe (2015) Bioequivalence and Food Effect Assessment for Vildagliptin/Metformin Fixed-dose Combination Tablets Relative to Free Combination of Vildagliptin and Metformin in Japanese Healthy Subjects. International Journal of Clinical Pharmacology and Therapeutics.
Abstract
Objective: To assess the bioequivalence of vildagliptin/metformin fixed-dose combination (FDC) tablets (50/250 mg and 50/500 mg) to free combinations of vildagliptin and metformin and the effect of food on the pharmacokinetics (PK) of vildagliptin and metformin following administration of a 50/500 mg FDC tablet.
Methods: Two open label, randomized, single-center, single-dose, 2-period crossover studies were conducted in Japanese male healthy volunteers. Participants were administered vildagliptin/metformin FDC tablet (Study I: 50/250 mg, Study II: 50/500 mg) or their free combination under fasted condition. Food effect (standard Japanese breakfast; composition: 20-30% from fat with approximately 600 kcal in total) was assessed in an additional period in Study II (50/500 mg). PK parameters (AUC, Cmax, Tmax, T1/2) were calculated for vildagliptin and metformin.
Results: For both studies, vildagliptin/metformin FDC tablets were bioequivalent to their respective free combinations. Administration of FDC tablet following a meal had no effect on vildagliptin PK parameters. The rate of absorption of metformin was decreased when given under fed condition, as reflected by a prolonged Tmax (from 3h in fasted state to 4h in fed state) and reduction in Cmax by 26%, but the extent of absorption (AUClast) was similar to fasted state.
Conclusions: The vildagliptin/metformin FDC tablets were bioequivalent to their free combinations. Food decreased metformin Cmax by 26% while AUClast was unchanged, consistent with previous reports. No food effect on vildagliptin Cmax or AUClast were observed. Therefore, food had no clinically relevant effect of metformin or vildagliptin pharmacokinetics.
| Item Type: | Article |
|---|---|
| Keywords: | Bioequivalence – vildagliptin – metformin – fixed-dose combination – food effect |
| Date Deposited: | 28 Apr 2016 23:45 |
| Last Modified: | 28 Apr 2016 23:45 |
| URI: | https://oak.novartis.com/id/eprint/26933 |
Tools
Tools